FDA Inspection 1249667 — John Hudson, M.D.
The FDA completed an inspection of John Hudson, M.D. on September 13, 2024 in Austin, TX. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Drugs.
Inspection Details
- Classification
- No Action Indicated (NAI) (NAI)
- End Date
- September 13, 2024
- Fiscal Year
- 2024
- Product Type
- Drugs
- Project Area
- Bioresearch Monitoring
- Location
- Austin, TX (United States)
Additional Details
Clinical Investigator (CI)